高达 30% 的患者会进展为呼吸肌无力，需要辅助呼吸。
Saiju Jacob, MD, DPhil, MRCP (UK), FRCP (Lon)
Queen Elizabeth Neurosciences Centre
University Hospital Birmingham
SJ is an Advisory Board member for Alexion Pharmaceuticals and Alnylam Pharmaceuticals. He lectures and is involved in other educational events for Terumo BCT and Eisai Ltd. He has attended clinical trial meetings as Chief/Principal Investigator for Argenx Ltd and Momenta Ltd.
Dr Saiju Jacob would like to gratefully acknowledge Dr John B. Winer, Dr Michael T. Torbey, Dr Dhruvil J. Pandya, and Dr Prem A. Kandiah, previous contributors to this topic.
JBW, MTT, DJP, and PAK declare that they have no competing interests.
Cigdem Akman, MD
Division of Pediatric Neurology
Columbia University College of Physicians and Surgeons
CA declares that he has no competing interests.
Robert Hadden, FRCP, PhD
King's College Hospital
RH has been paid by Baxter Healthcare Ltd for membership of its neurology advisory board, and is a co-author of several studies referenced in this topic.